Last $2.85 USD
Change Today -0.01 / -0.35%
Volume 108.8K
PSTI On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
Tel Aviv
As of 8:10 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank C. Carlucci

Head of Strategic Business Advisory Board, Pluristem Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 110 board members in 14 different organizations across 21 different industries.

See Board Relationships
83--

Background*

Mr. Frank C. Carlucci is a Senior Advisor and Member of Advisory Board of Monument Capital Group, LLC. He is a Co-Founder of Frontier Group. Mr. Carlucci serves as Counselor of Center for Strategic and International Studies, Inc. He served as a Managing Director of The Carlyle Group since 1989. He served as the Chairman of The Carlyle Group from 1993 to 2003. Since 1993, Mr. Carlucci served as the Chairman and Partner of The Carlyle Group and also served as its Vice ...

Read Full Background

Corporate Headquarters*

MATAM Advanced Technology Park
Haifa, -- 31905

Israel

Phone: 972 7 4710 7171
Fax: --

Board Members Memberships*

Chairman Emeritus
Chairman
Former Director
Chairman Emeritus
Director
Trustee Emerities
Chairman
1989-N/A
Chairman Emeritus
1989-N/A
Former Director
1989-N/A
Former Director
1989-N/A
Former Chairman of the Board
1990-Present
Director
1990-N/A
Former Director and Member of Compensation & Corporate Governance Committee
1994-N/A
Former Director
1995-N/A
Former Director
1997-Present
Director and Member of Nominating and Corporate Governance Committee
1998-Present
Director
2000-Present
Director
2006-Present
Vice Chairman, Member of Compensation Committee, Member of Audit Committee and Member of Executive Committee
2007-Present
Vice Chairman, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee

Education*

Unknown/Other Education
Harvard Business School
BA 1952
Princeton University
Honorary Doctorate 1989
University of Scranton

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PSTI:US $2.85 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$495.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Eamonn P. Hobbs Chief Executive Officer, President, Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee
Antares Pharma Inc.
--
Bernard A. Hausen M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Chief Medical Officer and Director
Cardica Inc.
$381.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLURISTEM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.